The fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, held in New York City, is devoted to exploring the latest research in cancer immunology and immunotherapy.
The 2018 meeting will take place at the New York Marriott Marquis from September 30-October 3, 2018. The program will focus on "Translating Science into Survival," and feature talks from more than 50 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy, including: regulating T cells and their response to cancer, tumor microenvironment, genetically engineered T cells, maintenance of immune balance, novel vaccine platforms and combinations, mutational analysis and predicting response to immunotherapy, convergence of technology and cancer immunotherapy, microbiome, and metabolism.
Visit the conference website today to view the program and register for the meeting. Abstract submission opens June 1 and closes July 16, 2018. Advance registration at discounted rates closes August 10, 2018.
Continuing Medical Education Activity AMA PRA Category 1 Credits™ are available.
The Cancer Research Institute (CRI), the Association for Cancer lmmunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to present the Fourth International Cancer lmmunotherapy Conference.
The official hashtag is #CICON18.
Do you have questions?